Our Mission: Curing rare disease in a single dose.
Just as enzyme replacement therapies (ERTs) revolutionized the past, gene therapy has the potential to revolutionize the future.
AVROBIO, Inc. is a clinical stage company focused on developing potentially curative ex vivo lentiviral-based gene therapies to treat rare diseases in a single dose.
Contact Us
Cambridge, MA
One Kendall Square,
Building 300,
Suite 201
Cambridge, MA 02139
USA
Phone: 617.914.8420
JLABS @ Toronto
MaRS Centre, West Tower
661 University Ave,
Suite 1300
Toronto, Ontario M5G 0B7
Canada